Skip to main content

Advertisement

SpringerLink
Log in

Analysis of HOX Gene Expression Patterns in Human Breast Cancer

  • Research
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

HOX genes are highly conserved transcription factors that determine the identity of cells and tissues along the anterior–posterior body axis in developing embryos. Aberrations in HOX gene expression have been shown in various tumors. However, the correlation of HOX gene expression patterns with tumorigenesis and cancer progression has not been fully characterized. Here, to analyze putative candidate HOX genes involved in breast cancer tumorigenesis and progression, the expression patterns of 39 HOX genes were analyzed using breast cancer cell lines and patient-derived breast tissues. In vitro analysis revealed that HOXA and HOXB gene expression occurred in a subtype-specific manner in breast cancer cell lines, whereas most HOXC genes were strongly expressed in most cell lines. Among the 39 HOX genes analyzed, 25 were chosen for further analysis in malignant and non-malignant tissues. Fourteen genes, encoding HOXA6, A13, B2, B4, B5, B6, B7, B8, B9, C5, C9, C13, D1, and D8, out of 25 showed statistically significant differential expression patterns between non-malignant and malignant breast tissues and are putative candidates associated with the development and malignant progression of breast cancer. Our data provide a valuable resource for furthering our understanding of HOX gene expression in breast cancer and the possible involvement of HOX genes in tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Rao, R. D., & Cobleigh, M. A. (2012). Adjuvant endocrine therapy for breast cancer. Oncology, 26, 541–547.

    Google Scholar 

  2. Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., et al. (2011). Adjuvant trastuzumab in HER2-positive breast cancer. New England Journal of Medicine, 365, 1273–1283.

    Article  CAS  Google Scholar 

  3. Giuliano, M., Schifp, R., Osborne, C. K., & Trivedi, M. V. (2011). Biological mechanisms and clinical implications of endocrine resistance in breast cancer. Breast, S3, S42–S49.

    Article  Google Scholar 

  4. Rexer, B. N., & Arteaga, C. L. (2012). Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: Mechanisms and clinical implications. Critical Reviews in Oncogenesis, 17, 1–16.

    Article  Google Scholar 

  5. Mann, R. S., & Affolter, M. (1998). Hox proteins meet more partners. Current Opinion in Genetics & Development, 8, 423–429.

    Article  CAS  Google Scholar 

  6. Favier, B., & Dollé, P. (1997). Developmental functions of mammalian Hox genes. Molecular Human Reproduction, 3, 115–131.

    Article  CAS  Google Scholar 

  7. Shah, N., & Sukumar, S. (2010). The Hox genes and their roles in oncogenesis. Nature Reviews Cancer, 10, 361–371.

    Article  CAS  Google Scholar 

  8. Svingen, T., & Tonissen, K. F. (2003). Altered HOX gene expression in human skin and breast cancer cells. Cancer Biology & Therapy, 2, 518–523.

    Article  CAS  Google Scholar 

  9. Cantile, M., Procino, A., Feliciello, I., Cindolo, L., & Cillo, C. (2003). In vivo expression of the whole HOX gene network in human breast cancer. European Journal of Cancer, 39, 257–264.

    Article  CAS  Google Scholar 

  10. Makiyama, K., Hamada, J., Takada, M., Murakawa, K., Takahashi, Y., Tada, M., et al. (2005). Aberrant expression of HOX genes in human invasive breast carcinoma. Oncology Reports, 13, 673–679.

    CAS  Google Scholar 

  11. Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., et al. (2000). Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature, 405, 974–978.

    Article  CAS  Google Scholar 

  12. Gilbert, P. M., Mouw, J. K., Unger, M. A., Lakins, J. N., Gbegnon, M. K., Clemmer, V. B., et al. (2010). HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. Journal of Clinical Investigation, 120, 1535–1550.

    Article  CAS  Google Scholar 

  13. Care, A., Silvani, A., Meccia, E., Mattia, G., Peschle, C., & Colombo, M. P. (1998). Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene, 16, 3285–3289.

    Article  CAS  Google Scholar 

  14. Jin, K., Kong, X., Shah, T., Penet, M. F., Wildes, F., Sgroi, D. C., et al. (2012). The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proceedings of the National Academy of Sciences of the United States of America, 109, 2736–2741.

    Article  CAS  Google Scholar 

  15. Carè, A., Felicetti, F., Meccia, E., Bottero, L., Parenza, M., Stoppacciaro, A., et al. (2001). HOXB7: A key factor for tumor-associated angiogenic switch. Cancer Research, 61, 6532–6539.

    Google Scholar 

  16. Hayashida, T., Takahashi, F., Chiba, N., Brachtel, E., Takahashi, M., Godin-Heymann, N., et al. (2010). HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proceedings of the National Academy of Sciences of the United States of America, 107, 1100–1105.

    Article  CAS  Google Scholar 

  17. Zhang, X., Zhu, T., Chen, Y., Mertani, H. C., Lee, K. O., & Lobie, P. E. (2003). Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. Journal of Biological Chemistry, 278, 7580–7590.

    Article  CAS  Google Scholar 

  18. Shaoqiang, C., Yue, Z., Yang, L., Hong, Z., Lina, Z., Da, P., et al. (2013). Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer. Clinical & Experimental Metastasis, 30, 155–163.

    Article  Google Scholar 

  19. Rodriguez, B. A., Cheng, A. S., Yan, P. S., Potter, D., Agosto-Perez, F. J., Shapiro, C. L., et al. (2008). Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. Carcinogenesis, 29, 1459–1465.

    Article  CAS  Google Scholar 

  20. Kao, J., Salari, K., Bocanegra, M., Choi, Y. L., Girard, L., Gandhi, J., et al. (2009). Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One, 4, e6146.

    Article  Google Scholar 

  21. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell, 10, 515–527.

    Article  CAS  Google Scholar 

  22. Hsiao, Y. H., Chou, M. C., Fowler, C., Mason, J. T., & Man, Y. G. (2010). Breast cancer heterogeneity: Mechanisms, proofs, and implications. Journal of Cancer, 1, 6–13.

    Article  Google Scholar 

  23. Morgan, R., Boxall, A., Harrington, K. J., Simpson, G. R., Gillett, C., Michael, A., et al. (2012). Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Research and Treatment, 136, 389–398.

    Article  CAS  Google Scholar 

  24. Di Pietro, M., Lao-Sirieix, P., Boyle, S., Cassidy, A., Castillo, D., Saadi, A., et al. (2012). Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proceedings of the National Academy of Sciences of the United States of America, 109, 9077–9082.

    Article  Google Scholar 

  25. Boimel, P. J., Cruz, C., & Segall, J. E. (2011). A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer. Genomics, 98, 164–172.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by funds from the National Health Insurance Service Ilsan Hospital (2010-01), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology (2010-0026759, 2010-0025149, 2013008399), and partly by a Grant from the BioGreen 21 Program, RDA, Korea (PJ00905601).

Author information

Authors and Affiliations

  1. Department of Surgery, National Health Insurance Service Ilsan Hospital, Goyang, 410-719, Korea

    Ho Hur

  2. Embryology Laboratory, Department of Anatomy, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, 120-752, Korea

    Ji-Yeon Lee, Hyo Jung Yun & Myoung Hee Kim

  3. Department of Surgery, Yonsei University College of Medicine, Seoul, 120-752, Korea

    Ho Hur & Byeong Woo Park

Authors
  1. Ho Hur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ji-Yeon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyo Jung Yun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Byeong Woo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Myoung Hee Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Myoung Hee Kim.

Additional information

Ho Hur, Ji-Yeon Lee, and Hyo Jung Yun have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hur, H., Lee, JY., Yun, H.J. et al. Analysis of HOX Gene Expression Patterns in Human Breast Cancer. Mol Biotechnol 56, 64–71 (2014). https://doi.org/10.1007/s12033-013-9682-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-013-9682-4

Keywords

Search

Navigation